Maksun Biotech’s growth is the result of supporting entrepreneurial dreams at the bottom level
Maksun Biotech Private Limited is an ISO-certified pharmaceutical venture by Ruchir Kumar Arora, Dr. Himanshu Arora, and Sh. Darshan Lal Arora. The company markets and sells a wide range of ethical and specialized drugs in the Indian market through its franchisees. The company that started its operations in 2013 operates on the PCD franchise model that has supported many talented youngsters realize their entrepreneurial dreams and has helped the company to consolidate its position in the competitive pharma domain.

At present Maksun Biotech Private Limited markets and sells 700 medicinal and cosmetic and derma care products as compared to 69 products in 2013 when it started its operation 2013. The pharma products marketed and sold by the company include cardiac, diabetic, pediatric, ophthalmic, gynaecologic, oncological, derma care, and critical care medicines. These products are marketed and sold under 9 brand names that include Blair Remedies, Gynaemak, Denblue, Chinvas Dental Care, Adrift Vision, Shinom Cosmoceuticals, Rehan Care, and Kenriz Care. Apart from this, the company has also entered into the selling of personalized highly effective, and efficient skincare range like face scrubs, face serums, face wash, sunscreen gel, under eye products, and face creams under the brand name Kaashmi Derm O Cos successfully listed and visible on all e-commerce platforms.
The founder trio Ruchir Kumar Arora, Himanshu Arora, and Darshan Lal Arora decided to adopt the PCD franchise model to market and sell the products with the vision that it would not only support the entrepreneurial dreams of many deserving and talented individuals by providing them with marketing and distributions rights to the company's wide range of quality products at a small investment but also help the company to establish itself against the prominent players in the segment.
The firm provides complete initial support to build franchises from the scratch by extending help in marketing, manufacturing business, and monopoly services. Its growth through the model can be understood by the fact that to date it has already helped 1000+ associates to launch and grow their business at the PAN India level. The firm provides franchisee opportunities primarily under pharmaceutical and derma care domains.
With the prerequisite of low capital requirements and high-profit margins, the company has been able to strengthen its position quickly across a large part of the country by providing monopoly rights to its franchisees, a lucrative opportunity for new entrepreneurs who prefer to avoid extensive competition and yet want to establish themselves in the market. The PCD model helps them to escape the burden of manufacturing and branding as they get already manufactured and branded products with the added benefit of prepared marketing manuals. This saves 80% of the efforts that require to launch a business, all one need is to provide the basic infrastructural support and the efforts to grow the franchisee that result in the growth of the company.
-
Thunderstorm Warning In Delhi NCR: IMD Issues Orange Alert Amid Sudden Weather Shift -
UP STF Nabs Maulana Abdullah Salim Over Controversial Comment On CM Yogi's Mother -
Masood Azhar’s Brother Mohammad Tahir Dies In Pakistan Under Mysterious Circumstances, Cause Yet To Be Known -
VerSe Innovation Appoints P.R. Ramesh as Independent Director and Chair of Audit Committee to Strengthen Governance Ahead of Next Phase of Growth -
“Not Going To Be There Too Much Longer”: Trump Signals Endgame In Iran War -
Iran Threatens To Hit US Companies in Region From April 1, Names Microsoft, Apple, Tesla, Boeing -
‘IPL Official’ Found Dead in Mumbai Hotel, Probe Underway -
Leander Paes To Contest West Bengal Assembly Elections 2026? Tennis Star Joins BJP Ahead of Assembly Polls -
April 1 Rule Changes: PAN, New Tax Law, ATM, FASTag, Cards to Impact Millions, What’s Changing? -
China, Pakistan Call for Immediate Ceasefire in Iran War, Push Peace Talks ‘As Soon As Possible’ -
Iran’s New Hormuz Plan Targets Global Shipping with Tolls, What Does It Mean? -
Are Banks Closed or Open Today on Mahavir Jayanti? RBI Issues Special March 31 Instructions












Click it and Unblock the Notifications